Skip to content

Clinical trials

Terminated Phase 1 Glioma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glioma Phase: Phase 1 Status: Terminated Clear all

55 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20052
20071
20081
20092
20102
20113
20124
20134
20145
20152
20162
20173
20185
20193
20203
20214
20221
20232
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated55

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)4
Nader Sanai3
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins3
Annick Desjardins2
Bexion Pharmaceuticals, Inc.2
M.D. Anderson Cancer Center2
Wake Forest University Health Sciences2
Amgen1
Boston Scientific Corporation1
Case Comprehensive Cancer Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glioma55
Glioblastoma23
Brain Neoplasms22
Astrocytoma17
Oligodendroglioma14
Gliosarcoma9
Neoplasms5
Central Nervous System Neoplasms4
Lymphoma, Follicular4
Medulloblastoma4

Trials

Showing 1 to 25 of 55. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.